Autosomal dominant disease
MONDO:0000426Autosomal dominant form of disease.
Also known as: autosomal dominant disease or disorder, autosomal dominant hereditary disorder, autosomal dominant inherited disorder, disease or disorder, autosomal dominant, disease, autosomal dominant
614 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
Community strategies show promise in curbing hazardous drinking
Disease control CompletedThis study tests a 5-week community-based program that teaches protective behavioral strategies to reduce alcohol use in men aged 35–44 with hazardous drinking habits in rural Vietnam. Participants learn to set safe drinking limits, choose nonalcoholic drinks, and plan ahead, wit…
Phase: NA • Sponsor: Chulalongkorn University • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New drug combo tested for tough breast cancer
Disease control CompletedThis study tested the safety of combining two drugs, alpelisib and fulvestrant, in 40 men and post-menopausal women with a certain type of advanced breast cancer (HR+, HER2-, with a PIK3CA mutation) that had worsened after hormone therapy. The goal was to track side effects. The …
Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Cholesterol-Lowering drug aims to stop first heart attacks
Disease control CompletedThis large study tested whether evolocumab (Repatha), a cholesterol-lowering injection, could reduce major cardiovascular events like heart attacks, strokes, or death in over 12,000 adults at high risk but without a prior heart attack or stroke. Participants received either evolo…
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Cancer patients get continued access to promising targeted therapy
Disease control CompletedThis study offers ongoing treatment with alectinib or crizotinib to about 200 adults with ALK- or RET-positive cancer who were already benefiting from these drugs in a previous Roche trial. The main goal is to monitor safety and side effects as patients continue therapy after the…
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Can a transplant drug stop HHT nosebleeds? small study tests sirolimus
Disease control CompletedThis small pilot study tested the safety and effectiveness of the oral drug sirolimus for reducing nosebleeds in people with hereditary hemorrhagic telangiectasia (HHT). Ten adults with moderate to severe nosebleeds took 2 mg of sirolimus daily for 3 months. Researchers tracked b…
Phase: PHASE2 • Sponsor: Unity Health Toronto • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Antioxidant drug shows promise for kids with NF1
Disease control CompletedThis study tested whether N-acetylcysteine (NAC), an antioxidant drug, can improve motor skills and learning in children with neurofibromatosis type 1 (NF1). Twenty-five children aged 8 to 16 took NAC or a placebo for 8 weeks. The goal was to see if NAC is safe and helps with mov…
Phase: PHASE2 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New drug combo shows promise for rare nerve tumors
Disease control CompletedThis phase 2 trial tested two drugs, selumetinib and sirolimus, in 21 people with advanced malignant peripheral nerve sheath tumors (MPNST), a rare cancer often linked to neurofibromatosis type 1. The goal was to see if the combination could shrink or stabilize tumors. The study …
Phase: PHASE2 • Sponsor: Sarcoma Alliance for Research through Collaboration • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Could a drug for acromegaly protect kidneys in polycystic disease?
Disease control CompletedThis Phase 3 trial tested whether lanreotide, a drug that blocks certain growth hormones, can slow the loss of kidney function in people with autosomal dominant polycystic kidney disease (ADPKD). The study included 159 adults with moderate kidney decline. Participants received ei…
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New hope for tough breast cancers: drug combo targets tumors in body and brain
Disease control CompletedThis phase 2 trial tested whether adding the drug veliparib to standard chemotherapy (cisplatin) helps people with metastatic triple-negative or BRCA-related breast cancer, including those with brain metastases. The study enrolled 344 participants to see if the combination slows …
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Could a cancer drug shrink NF2 tumors?
Disease control CompletedThis phase 2 trial tested the drug crizotinib in 12 people with neurofibromatosis type 2 (NF2) who had growing tumors in the ear area called vestibular schwannomas. Participants took crizotinib pills daily for up to 12 months. The main goal was to see if the drug could shrink the…
Phase: PHASE2 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Pump delivery of hormone may steady calcium levels in rare disorder
Disease control CompletedThis study tested two ways of delivering synthetic parathyroid hormone (PTH) to people with chronic hypoparathyroidism, a condition where the body doesn't make enough PTH, causing low calcium. Researchers compared using an insulin pump to give steady, small doses versus twice-dai…
Phase: PHASE2 • Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New gel could shrink neurofibroma tumors without surgery
Disease control CompletedThis phase 2 trial tested a gel called NFX-179 on skin tumors in 199 adults with neurofibromatosis type 1. Participants applied the gel daily for 26 weeks. The study measured safety and whether tumors shrank in size or height. Results suggest the gel may help reduce tumor volume,…
Phase: PHASE2 • Sponsor: NFlection Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Could a palm extract help fight a rare genetic brain disease?
Disease control CompletedThis study tested a supplement called HOV-12020 (made from palm tocotrienols) in 50 adults aged 45-75 with CADASIL, a rare genetic disease that damages small blood vessels in the brain, leading to strokes and memory loss. The goal was to see if the supplement could reduce worseni…
Phase: PHASE2 • Sponsor: Hovid Berhad • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Nerve block calms deadly heart storms in small trial
Disease control CompletedThis study tested a procedure that blocks certain nerves to the heart in 18 people with life-threatening, uncontrollable heart rhythm problems (called electrical storm). The goal was to see if it could reduce dangerous heart episodes and the need for defibrillator shocks. The app…
Sponsor: Jose Manuel López González • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Could a transplant drug tame tough vascular birthmarks?
Disease control CompletedThis phase 2 trial tested the drug sirolimus (rapamycin) in 61 children and young adults with complicated vascular anomalies—abnormal blood vessel growths that can cause pain, bleeding, or organ problems. The goal was to see if sirolimus could safely shrink these anomalies and im…
Phase: PHASE2 • Sponsor: Denise Martin Adams • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Drug could offer alternative to liver transplant for rare bleeding disorder
Disease control CompletedThis study tested a drug called bevacizumab in 25 adults with hereditary hemorrhagic telangiectasia (HHT) who had severe liver issues and high heart output. The goal was to see if the drug could improve heart function and reduce the need for a liver transplant, which requires lif…
Phase: PHASE2 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Kidney drug tolvaptan put to the test in Real-World japanese patients
Disease control CompletedThis study followed 1802 Japanese patients with autosomal dominant polycystic kidney disease (ADPKD) who were taking tolvaptan in real-world clinics. Researchers tracked safety and how well the drug slowed kidney growth. The goal was to see if tolvaptan works as well outside cont…
Sponsor: Otsuka Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New epilepsy drug shows promise in long-term safety trial
Disease control CompletedThis study tested the long-term safety of a drug called LP352 (bexicaserin) in 41 people aged 12 to 65 with severe epilepsy syndromes like Dravet or Lennox-Gastaut. Participants took the drug three times daily for up to 52 weeks. The main goal was to check for side effects, while…
Phase: PHASE2 • Sponsor: Longboard Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New hope for advanced colon cancer: immune drug shrinks tumors in genetic subtype
Disease control CompletedThis study tested whether the immunotherapy drug nivolumab, alone or with other drugs, can shrink tumors in people with colon cancer that has returned or spread. It included 385 participants whose tumors had a specific genetic feature called MSI-H or were non-MSI-H. The goal was …
Phase: PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New male pill aims to stop sperm production
Disease control CompletedThis study tested whether a daily oral pill can safely and temporarily lower sperm counts in healthy men to prevent pregnancy. Ninety-two men took either the experimental drug (DMAU) alone, DMAU plus another hormone (LNG), or a placebo for 12 weeks. The goal was to see if sperm c…
Phase: PHASE2 • Sponsor: Premier Research • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Gene therapy targets Alzheimer's in High-Risk group
Disease control CompletedThis early-stage trial tested a gene therapy called LX1001 in 15 people with Alzheimer's who have two copies of the APOE4 gene, a high-risk form. The therapy delivers a healthy APOE2 gene to try to change the course of the disease. The main goal was to check safety and side effec…
Phase: PHASE1, PHASE2 • Sponsor: Lexeo Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Hope for ataxia: experimental drug shows promise in Late-Stage trial
Disease control CompletedThis study tested a drug called troriluzole in 141 adults with spinocerebellar ataxia, a rare disease that affects balance and coordination. Participants took either the drug or a placebo daily for 8 weeks. The main goal was to see if troriluzole could improve symptoms like walki…
Phase: PHASE2, PHASE3 • Sponsor: Biohaven Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New hope for kids with brain tumors: targeted pill shows promise
Disease control CompletedThis study tested a drug called MEK162 in 105 children with low-grade gliomas or other tumors that have a specific overactive growth signal. The goal was to find the best dose, check for side effects, and see if the drug could shrink tumors. Children took the drug by mouth twice …
Phase: PHASE1, PHASE2 • Sponsor: Children's Hospital Los Angeles • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Pacemaker that thinks for itself could ease heart failure
Disease control CompletedThis study tested a pacemaker feature called AutoAdapt that automatically adjusts timing settings to help the heart pump better. It involved 198 people with heart failure who needed a special pacemaker. The goal was to see if this smart feature improves symptoms, reduces hospital…
Phase: NA • Sponsor: Biotronik SE & Co. KG • Aim: Disease control
Last updated Jun 26, 2026 18:44 UTC
-
Smartwatch and ring take on the 12-Lead ECG in heart rhythm showdown
Diagnosis CompletedThis study tested whether two wearable devices—the Apple Watch and the Skylab CART-I ring—can accurately detect atrial fibrillation and other irregular heart rhythms compared to the standard 12-lead ECG. Researchers recruited 500 adults from UK cardiology clinics. Each participan…
Phase: NA • Sponsor: Oxford University Hospitals NHS Trust • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
New heart mapping device could make arrhythmia treatments more precise
Diagnosis CompletedThis study tested a non-invasive mapping system (Cardioinsight®) to help doctors treat heart rhythm disorders. It included 492 patients who needed ablation, pacemaker implantation, or risk assessment for sudden death. The goal was to see if the mapping system improves outcomes co…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Diagnosis
Last updated Jun 27, 2026 12:34 UTC
-
New ultra-low-dose CT scan aims to protect kids with rare blood vessel disorder
Diagnosis CompletedThis study tested a new ultra-low-dose chest CT technique in 3 children (ages 1-17) with hereditary hemorrhagic telangiectasia (HHT) to see if it could detect abnormal blood vessels in the lungs (PAVMs) using much less radiation than standard CT. The goal was to find the lowest p…
Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Jun 27, 2026 12:23 UTC
-
AI boosts colonoscopy accuracy for lynch syndrome patients?
Diagnosis CompletedThis study tested whether using artificial intelligence (AI) during colonoscopy helps find more polyps in people with Lynch syndrome, a genetic condition that raises colon cancer risk. One hundred participants each had two colonoscopies back-to-back, with the second using either …
Phase: NA • Sponsor: Sheba Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 12:10 UTC
-
IPhone heart monitor put to the test for QT interval accuracy
Diagnosis CompletedThis study tested whether an iPhone ECG device (AliveCor) can accurately measure the QT interval of the heart compared to a standard 12-lead ECG. Researchers studied 29 hospitalized patients starting medications that can affect the QT interval. The goal was to see if the iPhone r…
Phase: NA • Sponsor: University of Oklahoma • Aim: Diagnosis
Last updated Jun 27, 2026 12:04 UTC
-
New vest-like device could map heart rhythm problems without needles
Diagnosis CompletedThis study tested a new non-invasive tool called ECG-Imaging that uses many electrodes on the body to create a 3D map of the heart's electrical activity. The goal was to see if it can more accurately locate the source of heart rhythm problems compared to a standard ECG. 362 parti…
Sponsor: Corify Care S.L. • Aim: Diagnosis
Last updated Jun 27, 2026 09:06 UTC
-
New brain wave test could revolutionize hearing loss diagnosis
Diagnosis CompletedThis study tested a new device called CochSyn that measures brain waves to detect hearing damage. Researchers compared results from 65 adults with and without hearing difficulties. The goal was to see if the device can accurately identify different types of hearing loss and be ea…
Phase: NA • Sponsor: University Ghent • Aim: Diagnosis
Last updated Jun 27, 2026 09:03 UTC
-
New Gadolinium-Free MRI dye shows promise for brain scans
Diagnosis CompletedThis study tested a new MRI contrast agent called RVP-001, made with manganese instead of gadolinium, in 18 adults with known brain lesions (like tumors or multiple sclerosis). The goal was to see if it is safe and can detect lesions as well as current gadolinium-based dyes. Each…
Phase: PHASE2 • Sponsor: Reveal Pharmaceuticals Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 08:06 UTC
-
Simple blood test could spot Alzheimer's early
Diagnosis CompletedThis study is working on a blood test to help diagnose Alzheimer's disease. Researchers are measuring two specific markers in the blood of 200 people—some with Alzheimer's and some healthy—to see if these markers can reliably tell the difference. The goal is to create a simple, n…
Sponsor: Amoneta Diagnostics SAS • Aim: Diagnosis
Last updated Jun 27, 2026 08:05 UTC
-
Sugar alcohol infusion may help diagnose thirst disorders
Diagnosis CompletedThis study tested whether infusing mannitol, a sugar alcohol, can help diagnose polyuria-polydipsia syndrome—a condition of excessive thirst and urination. Researchers measured copeptin levels in 42 healthy adults and patients after mannitol or placebo infusion. The goal was to s…
Phase: NA • Sponsor: University Hospital, Basel, Switzerland • Aim: Diagnosis
Last updated Jun 27, 2026 08:04 UTC
-
Could a simple skin zap spot melanoma sooner?
Diagnosis CompletedThis study looked at whether a device called Nevisense, which measures the electrical properties of moles, can help doctors better assess suspicious moles during routine skin checks. Forty adults with many moles (at least 100) and several large moles took part. The goal is to imp…
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 07:58 UTC
-
New blood test could replace risky prenatal procedures for genetic diseases
Diagnosis CompletedThis study aimed to develop a non-invasive prenatal test using fetal cells from a mother's blood to detect triplet repeat diseases like Huntington's disease, Fragile X syndrome, and certain types of muscular dystrophy and ataxia. Researchers enrolled 60 pregnant women at risk and…
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Diagnosis
Last updated Jun 27, 2026 07:53 UTC
-
New ultra-low dose CT could slash radiation for HHT lung checks
Diagnosis CompletedThis study tested whether an ultra-low dose chest CT scan can find lung blood vessel malformations in people with hereditary hemorrhagic telangiectasia (HHT) as well as the standard low-dose CT scan, but with much less radiation. 45 HHT patients received both scans, and radiologi…
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Diagnosis
Last updated Jun 26, 2026 15:38 UTC
-
Virtual fitness and nutrition program aims to keep older men on their feet
Prevention CompletedThis pilot study tested a virtual program designed to help older men at high risk for fractures reduce their risk of falls and broken bones. The program included personalized exercise plans delivered through a smartphone app and virtual nutrition counseling. Researchers enrolled …
Phase: NA • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Prevention
Last updated Jun 27, 2026 12:10 UTC
-
Teens with NF try video coaching to boost mood and health
Symptom relief CompletedThis study tested two 8-week stress management programs delivered via secure video calls for 196 adolescents aged 12–17 with neurofibromatosis (NF1 or NF2). The goal was to see if these programs could improve emotional, social, and physical quality of life. Both programs taught c…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
Acupuncture needles vs. sham: does it really help Alzheimer's?
Symptom relief CompletedThis study tested whether adding acupuncture to standard care can slow down memory and thinking problems in people with mild Alzheimer's disease. Researchers compared real acupuncture to a fake (sham) procedure in 160 participants to see if the effects were real or just a placebo…
Phase: NA • Sponsor: Shanghai Institute of Acupuncture, Moxibustion and Meridian • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
Epidiolex shows promise for easing seizures and behavior issues in TSC
Symptom relief CompletedThis study looked at whether adding Epidiolex (a CBD-based medicine) to usual treatment can improve seizures, behavior, sleep, and quality of life in people aged 1 to 65 with tuberous sclerosis complex (TSC). 79 participants took the drug and were monitored for changes in symptom…
Phase: PHASE4 • Sponsor: Jazz Pharmaceuticals • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
Could a common supplement help kids with NF1 learn and move better?
Symptom relief CompletedThis study tested whether N-acetylcysteine (NAC), an over-the-counter antioxidant, could improve learning and motor skills in children with neurofibromatosis type 1 (NF1). Five children aged 8 to 16 took NAC or a placebo to see if it helped with movement and attention problems. T…
Phase: PHASE2 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Remote therapy shows promise for TSC behavior issues in preschoolers
Symptom relief CompletedThis study looked at behavior problems in 101 children aged 3 to 6 with tuberous sclerosis complex (TSC). Families completed assessments online, and those with elevated behavior issues were offered a parent-training therapy (PCIT) over the internet. The goal was to help parents m…
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
Exercise program shows promise for marfan syndrome patients
Symptom relief CompletedThis study tested a personalized exercise program for 28 children and young adults with Marfan syndrome, a rare genetic condition affecting the heart, eyes, and bones. The program aimed to improve endurance, muscle strength, and quality of life. Researchers measured changes in fi…
Phase: NA • Sponsor: University Hospital, Toulouse • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
New drug PB shows promise for slowing excessive urination in kidney patients
Symptom relief CompletedThis study tested whether the medication PB can safely reduce excessive urination in people with certain kidney diseases, including inherited nephrogenic diabetes insipidus, lithium-induced diabetes insipidus, and polycystic kidney disease treated with tolvaptan. Researchers meas…
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Video-Based stress program aims to ease life with neurofibromatosis
Symptom relief CompletedThis study tested two stress and symptom management programs for adults with neurofibromatosis (NF1, NF2, or schwannomatosis). The programs were delivered through live videoconferencing over 8 weekly sessions. Researchers measured changes in quality of life and emotional well-bei…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
Chill out: skin cooling may ease pain of NF1 treatments
Symptom relief CompletedThis study tested whether cooling the skin before or during laser and injection treatments for neurofibromatosis type 1 (NF1) skin bumps can reduce pain. Thirteen adults with NF1 received four different treatments (two lasers and two injections) on both cooled and non-cooled skin…
Phase: PHASE1 • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
Snap and scribble: a new way to cope with marfan syndrome?
Symptom relief CompletedThis study looked at whether taking pictures and writing about them can help people with Marfan syndrome express their feelings and improve their sense of well-being. Eight adults with Marfan syndrome took part in photography and writing activities, then shared their experiences …
Phase: NA • Sponsor: IRCCS Policlinico S. Donato • Aim: Symptom relief
Last updated Jun 26, 2026 15:32 UTC
-
Scientists uncover genetic secrets behind rare hormone disorders
Knowledge-focused CompletedThis study looked at nearly 1,400 people with rare conditions like PPNAD, Carney Complex, and Peutz-Jeghers syndrome. The goal was to find the genetic causes and link them to specific symptoms. Researchers used clinical exams and genetic testing to better understand how these dis…
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Scientists track skin tumors in NF1 to uncover clues for future therapies
Knowledge-focused CompletedThis study followed 17 adults with neurofibromatosis type 1 (NF1) over two years to learn how their skin tumors (dermal neurofibromas) grow and change. Researchers used special cameras and skin biopsies to measure tumor growth and look for genes that might influence it. The goal …
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
NIH launches study to unravel mysteries of rare genetic brain disease CADASIL
Knowledge-focused CompletedThis study looked at 20 people with CADASIL, a rare genetic disease that damages brain arteries and causes migraines, strokes, and dementia. Researchers used blood tests, skin biopsies, eye exams, and brain scans to learn more about how the disease works. The goal was to better u…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Fizzy drink study probes saliva secrets
Knowledge-focused CompletedThis study investigates how flavored carbonated drinks change saliva flow, composition, and taste perception compared to plain water, carbonated water, or non-carbonated drinks. Healthy adults aged 18-45 who regularly drink carbonated beverages will provide saliva samples after t…
Phase: NA • Sponsor: PepsiCo Global R&D • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
New scan and genetic tests aim to catch cancer early in NF1 patients
Knowledge-focused CompletedThis study looked at people with neurofibromatosis type 1 (NF1) to better understand how harmless tumors (plexiform neurofibromas) turn into a rare cancer called MPNST. Ten participants had MRI, PET scans, and tumor biopsies. Researchers tested whether a special PET scan (FLT PET…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Gene hunt aims to unlock NF1's mysteries
Knowledge-focused CompletedThis study looks at people with neurofibromatosis type 1 (NF1) and their families to find out why some have more severe symptoms than others. Researchers will collect medical history, blood samples, and images to study genes and physical traits. The goal is to identify genes that…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
New study tracks how a common heart valve performs in people born with a bicuspid valve
Knowledge-focused CompletedThis study follows 150 people with bicuspid aortic stenosis—a narrowed heart valve present from birth—who receive a transcatheter aortic valve replacement (TAVI) using the Evolut Pro or Evolut R XL device. Researchers will measure how well the valve works over time, including blo…
Sponsor: Clinique Pasteur • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Texts and nudges may help more people get cancer genetic testing
Knowledge-focused CompletedThis study tested three types of messages to encourage genetic testing in 1,283 people at risk for hereditary breast and ovarian cancer. Participants received an electronic health record message, then a text message, then a doctor's reminder if needed. The goal was to see which a…
Phase: NA • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Frozen tumors, clearer vision? scientists dig into 20 years of eye records
Knowledge-focused CompletedThis study looks back at 20 years of medical records from 25 people who had a freezing treatment (cryotherapy) for retinal hemangioblastoma, a rare eye tumor often linked to von Hippel-Lindau disease. Researchers want to see how well the treatment controlled the tumors and affect…
Sponsor: National Eye Institute (NEI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Could a simple calculation replace a complex testosterone lab test?
Knowledge-focused CompletedThis study compared two methods for measuring bioavailable testosterone in the blood: the standard lab test (radioimmunoassay) and a mathematical calculation. Researchers included 270 men and women aged 18 to 90. The goal was to see if the calculation matches the lab test closely…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Lynch syndrome patients share colonoscopy struggles in new survey
Knowledge-focused CompletedThis study surveyed 231 adults with Lynch syndrome, an inherited condition that raises bowel cancer risk. Researchers wanted to find out how many people follow the UK recommendation of a colonoscopy every two years, and what makes it harder or easier to keep up with these check-u…
Sponsor: Imperial College London • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC
-
Peer coaching may ease distress for young women facing breast cancer risk
Knowledge-focused CompletedThis study looked at whether a 3-session peer coaching program over the phone could help young women (ages 21–30) who have a family history of BRCA mutations. The goal was to see if it reduces cancer-related distress and helps them make informed decisions about genetic counseling…
Phase: NA • Sponsor: Georgetown University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
New MRI scan could replace painful kidney biopsies for transplant patients
Knowledge-focused CompletedThis study tested a special MRI technique called magnetic resonance elastography (MRE) to see if it can detect scarring in transplanted kidneys. Researchers compared MRE results with traditional biopsy samples from 73 kidney transplant patients. The goal was to find a non-invasiv…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Family study aims to unlock secrets of hereditary breast and ovarian cancer
Knowledge-focused CompletedThis completed study enrolled 377 individuals and families with a high risk of breast or ovarian cancer due to known or suspected genetic factors. Researchers collected medical records, questionnaires, and biological samples to better understand the disease's natural history and …
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Massive study digs into genetic roots of stomach cancer
Knowledge-focused CompletedThis study collected information from 733 people with a personal or family history of hereditary stomach cancer. The goal was to better understand how these cancers develop and what genes are involved. Participants provided medical history, blood samples, and genetic testing. The…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
New heart monitor algorithm put to the test
Knowledge-focused CompletedThis study looked at how well a new heart monitor (Assert-IQ) detects atrial fibrillation (an irregular heartbeat) in people who have had a heart ablation procedure. 151 participants wore the monitor as part of their normal care. Researchers compared the monitor's readings to a s…
Sponsor: Abbott Medical Devices • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
New digital platform aims to break the silence around hereditary cancer in families
Knowledge-focused CompletedThis study tested a digital health platform to help people with a hereditary risk of breast and ovarian cancer share their genetic test results with family members. Researchers worked with 128 participants in Switzerland and Korea to see if the tool reduced distress and improved …
Phase: NA • Sponsor: University of Basel • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
Computer study tests if newer radiation beams can better treat deadly heart condition
Knowledge-focused CompletedThis study used computer simulations to compare three types of radiation (photons, protons, and carbon ions) for treating a dangerous heart rhythm called ventricular tachycardia. Researchers created treatment plans for 23 patients who were already scheduled for standard catheter …
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
Can estrogen boost the 'Love Hormone' in a rare condition?
Knowledge-focused CompletedThis pilot study tested whether a single dose of oral estrogen-progestin can raise oxytocin levels in people with arginine vasopressin deficiency (AVD), a rare condition that also causes low oxytocin. Researchers compared 28 adults—some with AVD and some healthy—to see if oxytoci…
Phase: EARLY_PHASE1 • Sponsor: Elizabeth Austen Lawson • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
Walking analysis sheds light on rare genetic disorders
Knowledge-focused CompletedThis study looked at whether a special walking test (3D gait analysis) can help identify movement problems in people with rare genetic diseases like Tuberous Sclerosis and STXBP1. About 40 participants aged 6 and older who could walk without help took part. The goal was to see if…
Sponsor: Universiteit Antwerpen • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
Heart monitor registry tracks safety in nearly 2,000 patients
Knowledge-focused CompletedThis study tracked 1,826 people who received a small implantable heart monitor (Confirm Rx) to check for irregular heartbeats. Over 12 months, researchers recorded how often the device caused serious problems and how well it worked in daily life. The goal was to see if the monito…
Sponsor: Abbott Medical Devices • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Gene study seeks clues to Longer-Lasting kidney transplants
Knowledge-focused CompletedThis study looked at whether certain gene variations affect how well a transplanted kidney works over time. Researchers checked 80 kidney transplant recipients for specific gene markers and measured their kidney function for up to three years. The goal was to find clues that coul…
Phase: NA • Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Large study tracks kidney disease progression in thousands of patients
Knowledge-focused CompletedThis study followed over 3,400 people with autosomal dominant polycystic kidney disease (ADPKD) to learn how the disease progresses. Researchers measured kidney size, symptoms, quality of life, and healthcare costs. The goal was to identify factors that predict faster disease pro…
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Large study aims to predict brain bleeds in rare HHT disorder
Knowledge-focused CompletedThis study looked at over 2,200 people with hereditary hemorrhagic telangiectasia (HHT), a rare condition that causes abnormal blood vessels. The goal was to find out what makes some people with HHT more likely to have a brain bleed. Researchers collected health information, bloo…
Sponsor: Unity Health Toronto • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Men shape their own suicide prevention tools in new study
Knowledge-focused CompletedThis completed study brought together men who have had suicidal thoughts to help design suicide prevention tools. Over up to 10 meetings, 13 men gave feedback on tool drafts, focusing on usability, privacy, and support. The goal was to create resources that truly fit their needs.
Phase: NA • Sponsor: University Ghent • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Teens and parents share feelings on genetic risk results
Knowledge-focused CompletedThis study explored how teenagers and their parents react emotionally and mentally when they learn about genetic risks for conditions like hereditary breast cancer, Lynch syndrome, or high cholesterol. Researchers surveyed 162 participants using questionnaires and interviews to m…
Phase: EARLY_PHASE1 • Sponsor: Geisinger Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
New tech aims to catch drunk drivers before they crash
Knowledge-focused CompletedThis study tested a system that uses car sensors and machine learning to tell if a driver is drunk. 55 volunteers drove a real car after drinking alcohol. The goal was to create an algorithm that can spot impaired driving and warn the driver.
Phase: NA • Sponsor: University of Bern • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
Drug interaction study: VX-407 and oral contraceptives
Knowledge-focused CompletedThis study looked at how a new drug called VX-407 changes the way birth control pills work in the body. 74 healthy adults took VX-407 along with different types of oral contraceptives. The goal was to see if VX-407 affects the levels of these contraceptives, which is important fo…
Phase: PHASE1 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC
-
Can an online program help african american women learn their genetic cancer risk?
Knowledge-focused CompletedThis completed study tested whether an online self-guided program could effectively return genetic test results for hereditary breast and ovarian cancer to African American women. Over 900 women from the Black Women's Health Study were offered their results online or by printed m…
Phase: NA • Sponsor: Boston University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC
-
Healthy volunteers test new drug for kidney disease
Knowledge-focused CompletedThis early-stage study tested the safety and how the body handles a new drug called VX-407 in 32 healthy adults. The goal was to check for side effects and measure drug levels in the blood. No treatment benefit was expected, as this study was designed to gather safety information…
Phase: PHASE1 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Vibrating platforms change reflex timing, small study finds
Knowledge-focused CompletedThis study looked at how standing on a vibrating platform affects spinal reflexes in 15 healthy adults. Participants stood in different positions with or without vibration while researchers measured electrical signals from a leg muscle. The goal was to understand how vibration ch…
Phase: NA • Sponsor: Istanbul Physical Medicine Rehabilitation Training and Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Tiny gene study may unlock clues to kidney disease in bergamo families
Knowledge-focused CompletedThis study examined 10 people with autosomal dominant polycystic kidney disease (ADPKD) to see if a specific deletion in the PKD2 gene is shared among families in the Bergamo area. Researchers interviewed participants and built family trees to understand how the gene change affec…
Sponsor: Mario Negri Institute for Pharmacological Research • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Heart transplant warning: could a simple virus test spot rejection early?
Knowledge-focused CompletedThis study followed 60 heart transplant patients for one year to see if levels of a harmless virus called TTV in the blood are linked to infections or organ rejection. Researchers took monthly blood samples alongside routine care. The goal is to find a new way to monitor transpla…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Brain scans reveal hidden clues in rare stroke disorder
Knowledge-focused CompletedThis study looked at how blood flow and brain activity are linked in people with CADASIL, a rare genetic disease that causes small strokes. Researchers used MRI and EEG scans to measure these connections in 60 adults. The goal was to better understand the disease, not to test a n…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:11 UTC
-
New study maps key tests for LGMD to speed up drug development
Knowledge-focused CompletedThis study involved 116 people with Limb Girdle Muscular Dystrophy (LGMD), a group of rare muscle-weakening disorders. Researchers measured how well participants could walk, move their arms, and breathe, and asked about their daily activities and overall health. The goal was to i…
Sponsor: Virginia Commonwealth University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
Finger length may offer clues to breast cancer risk
Knowledge-focused CompletedThis study looked at whether the ratio of index to ring finger length (2D:4D) is different in women with breast cancer compared to healthy women. Researchers measured the fingers of 132 women (79 with breast cancer, 53 without) and checked if the ratio related to tumor markers in…
Sponsor: Malatya Turgut Ozal University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
Marfan Patients' hidden struggles after heart surgery revealed
Knowledge-focused CompletedThis study looked at how heart surgery impacts the mental health, well-being, and quality of life of adults with Marfan Syndrome. Researchers asked 28 patients to fill out questionnaires about depression, fatigue, pain, and self-esteem before surgery and at several points after. …
Sponsor: Barts & The London NHS Trust • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
Large study looks at how a 25-Gene cancer test affects patients and families
Knowledge-focused CompletedThis study looked at how a genetic test that checks 25 genes linked to hereditary cancers is used in clinics. Over 1,500 people with a personal or family history of cancer took part. Researchers collected blood samples and had participants fill out questionnaires over five years …
Sponsor: University of Southern California • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
DNA hunt for early Alzheimer's clues
Knowledge-focused CompletedThis study collected blood and DNA samples from 26 people with early-onset Alzheimer's disease and their close family members. Researchers analyzed the samples to find genetic changes and biomarkers that could help doctors diagnose, treat, and monitor the disease in the future. T…
Sponsor: Baylor Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Could changing your gut bacteria protect your memory?
Knowledge-focused CompletedThis study looked at the gut microbiome (the bacteria living in the digestive tract) of 44 people with mild cognitive impairment, early Alzheimer's, or healthy memory. Researchers wanted to see if lifestyle changes could alter the gut microbiome and whether those changes might be…
Sponsor: George Washington University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Scientists hunt for genetic clues to aortic aneurysm risk
Knowledge-focused CompletedThis study collected blood and tissue samples from 91 adults with aortic valve disease to look for genetic differences that might explain why some develop aortic aneurysms. Researchers compared gene activity in people with bicuspid valves, tricuspid valves, and healthy controls. …
Sponsor: Baylor Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:14 UTC
-
Gene-Face link in rare syndromes revealed
Knowledge-focused CompletedThis study examined 39 children aged 4 to 18 with Marfan or Loeys-Dietz syndromes to see how their genetic differences relate to facial and jaw structure. Researchers used X-rays to measure bone relationships in the face and compared groups based on their specific gene changes. T…
Sponsor: Andrea Scribante • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
New anesthesia drug checked for heart risks in healthy volunteers
Knowledge-focused CompletedThis completed early-stage study looked at whether a single dose of HSK3486, an anesthesia drug, changes the heart's electrical activity in 48 healthy adults aged 18 to 45. The main goal was to measure any effects on heart repolarization (QTc interval) and check for side effects.…
Phase: PHASE1 • Sponsor: Haisco-USA Pharmaceuticals, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC
-
20-Year study tests precision medicine for rare Brain-Skin disorders
Knowledge-focused CompletedThis completed study looked at 1,200 people with neurocutaneous syndromes (NF1, TSC, SWS, VHL) in Western China. Researchers compared those who received genetic testing, targeted drugs, and coordinated specialist care against those who got standard care. The goal was to see if pr…
Sponsor: West China Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC
-
530 canadians with kidney disease share real-world drug results
Knowledge-focused CompletedThis study followed 530 adults with autosomal dominant polycystic kidney disease (ADPKD) who were already taking the drug tolvaptan (JINARC™). Researchers wanted to see how the medication affected their quality of life, pain, and daily activities, as well as how long it took befo…
Sponsor: Otsuka Canada Pharmaceutical Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC
-
New study reveals IVF success for kidney disease carriers
Knowledge-focused CompletedThis study looked at 44 couples where one or both partners have polycystic kidney disease (PKD). They used IVF combined with genetic testing to select embryos without the disease. The goal was to see how often these treatments led to a healthy pregnancy and live birth, and to tra…
Sponsor: Azienda Sanitaria Universitaria Integrata del Trentino • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
Urine test may replace needle biopsy for kidney transplant patients
Knowledge-focused CompletedThis study looked at whether a simple urine test could predict scarring in kidney transplants, instead of using a needle biopsy. Researchers measured certain genetic markers in urine cells from 300 kidney transplant recipients over the first year after transplant. The goal was to…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
Exercise echo may catch silent heart failure in rare HHT liver disease
Knowledge-focused CompletedThis completed pilot study looked at 47 adults with hereditary hemorrhagic telangiectasia (HHT) who also have liver involvement. Researchers used exercise echocardiography (heart ultrasound while pedaling) to measure lung artery pressure during exercise. The goal was to see if th…
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
New algorithm tested to improve heart ablation for AFib
Knowledge-focused CompletedThis study tested a new computer algorithm that analyzes heart signals during a procedure called ablation for persistent atrial fibrillation (a type of irregular heartbeat). The goal was to see if the system could collect and process these signals to help doctors better understan…
Sponsor: CathVision ApS • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC
-
Can mindfulness help young adults with a high cancer risk?
Knowledge-focused CompletedThis study tested whether a mindful self-compassion program could be adapted for young adults aged 18 to 29 with Li-Fraumeni syndrome, a genetic condition that greatly raises cancer risk. Seven participants attended a one-day demonstration and gave feedback on how to make the pro…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
Scientists hunt for genes behind NF1 skin tumors
Knowledge-focused CompletedThis completed study at Stanford University looked at the DNA of over 1,000 adults with Neurofibromatosis Type 1 (NF1) to find genetic differences that might explain why some people develop more skin neurofibromas than others. Participants provided blood or saliva samples for gen…
Sponsor: Stanford University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC
-
Scientists hunt for genes behind rare kidney disease
Knowledge-focused CompletedThis study looked at 225 adults with a rare, inherited form of kidney disease to find the genetic causes. Participants had chronic kidney failure and often had a family history of gout. Researchers tested for known gene mutations and searched for new ones in families without a cl…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC
-
Researchers track rare hormone disorder in 133 patients
Knowledge-focused CompletedThis study followed 133 people with PPNAD (a rare adrenal gland disorder) or Carney Complex (a related genetic condition) for three years. The goal was to better understand the symptoms and genetic causes of these diseases, not to test a new treatment. Participants had yearly che…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
Milk-Free diet may boost gut defenses in allergic infants
Knowledge-focused CompletedThis study looked at 34 breastfed infants under 6 months old with cow's milk protein allergy. Researchers wanted to see if a cow's milk elimination diet for mothers and babies could improve symptoms, growth, and gut immune markers like MUC2 and sIgA. They collected stool samples …
Sponsor: Baskent University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC
-
New drug interaction study aims to make radiprodil safer for future use
Knowledge-focused CompletedThis study tested how the experimental drug radiprodil interacts with five common medications (warfarin, midazolam, digoxin, rosuvastatin, and omeprazole) in 18 healthy adults. Participants took radiprodil alone and then with each of these drugs to measure changes in drug levels …
Phase: PHASE1 • Sponsor: GRIN Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC
-
Brain scan and spinal tap study aims to speed up ataxia drug trials
Knowledge-focused CompletedThis completed study looked at 40 people with spinocerebellar ataxia types 2 and 7, a rare brain disease that affects movement. Researchers used MRI scans and lumbar punctures over one year to track changes in the brain and body. The goal was to find reliable markers that could b…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC
-
Could a single DNA test solve the mystery of rare brain diseases in kids?
Knowledge-focused CompletedThis study looked at whether whole genome sequencing (a complete read of a person's DNA) can help diagnose leukodystrophies, a group of rare brain diseases that are hard to identify. Researchers enrolled 236 children with white matter abnormalities on brain scans but no known gen…
Sponsor: Children's Hospital of Philadelphia • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC
-
Universal DNA screening in endometrial cancer reveals hidden genetic risks
Knowledge-focused CompletedThis study tested over 1,000 women with endometrial cancer for DNA repair problems that can be inherited (Lynch syndrome). By analyzing tumor DNA, researchers aimed to personalize cancer treatment and identify family members who might also be at risk. The goal was to improve care…
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC
-
New study reveals how HHT symptoms impact daily life
Knowledge-focused CompletedThis study looked at how symptoms of hereditary hemorrhagic telangiectasia (HHT) affect patients' quality of life. Researchers used a special questionnaire developed with patient input to measure different aspects like physical limits, worry about bleeding, and social relationshi…
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
Rare genetic Disorder's mental health patterns explored
Knowledge-focused CompletedThis study looked at 25 people with FOXP1 syndrome, a rare genetic condition, to better understand their psychiatric symptoms. Researchers used interviews and questionnaires with families to assess hyperactivity, attention, anxiety, autism traits, and more. The goal is to improve…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 26, 2026 19:02 UTC
-
Are heart patients moving enough? new study investigates
Knowledge-focused CompletedThis completed study from the University of São Paulo measured physical activity levels and quality of life in 100 adults with cardiac arrhythmias. Researchers used questionnaires to see how active patients were and how they felt physically and mentally. The goal was to understan…
Sponsor: University of Sao Paulo • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:25 UTC
-
Can genetic screening help prevent cancer in underserved communities?
Knowledge-focused CompletedThis study looked at whether offering exome sequencing (a detailed genetic test) along with tailored genetic counseling helps people at high risk for hereditary cancer syndromes understand their risk and take action. Nearly 1,000 adults from diverse backgrounds in Colorado and Or…
Phase: NA • Sponsor: Kaiser Permanente • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:54 UTC
-
Marfan study sheds light on spinal issues linked to dural ectasia
Knowledge-focused CompletedThis study looked at 90 adults with Marfan syndrome to compare spinal symptoms and daily limitations between those who have dural ectasia (a widening of the spinal sac) and those who do not. Researchers used questionnaires to measure pain, activity limits, and quality of life. Th…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:11 UTC
-
Eye tests reveal clues about neurofibromatosis
Knowledge-focused CompletedThis completed study looked at how the pigment layer of the eye works in 30 people with neurofibromatosis type 1. Researchers used special eye tests to measure electrical signals from the pigment layer and compared them to images of the back of the eye. The goal was to confirm ea…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:46 UTC
-
Cord blood study could unlock new HHT treatments
Knowledge-focused CompletedThis study collected umbilical cord blood and tissue from 16 newborns who have a parent with hereditary hemorrhagic telangiectasia (HHT), a genetic disorder causing abnormal blood vessels. Researchers aim to grow and compare endothelial cells from these babies with cells from hea…
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 26, 2026 13:00 UTC